Pattern recognitions receptors in immunodeficiency disorders

File Description SizeFormat 
PRRs immunodeficiency disorders.docxAccepted version117.03 kBMicrosoft WordView/Open
Title: Pattern recognitions receptors in immunodeficiency disorders
Authors: Mortaz, E
Adcock, IM
Tabarsi, P
Darazam, IA
Movassaghi, M
Garssen, J
Jamaati, H
Velayati, A
Item Type: Journal Article
Abstract: Pattern recognition receptors (PRRs) recognize common microbial or host-derived macromolecules and have important roles in early activation and response of the immune system. Initiation of the innate immune response starts with the recognition of microbial structures called pathogen associated molecular patterns (PAMPs). Recognition of PAMPs is performed by germline-encoded receptors expressed mainly on immune cells termed pattern recognition receptors (PRRs). Several classes of pattern recognition receptors (PRRs) are involved in the pathogenesis of diseases, including Toll-like receptors (TLRs), C-type lectin receptors (CLRs), and Nod-like receptors (NLRs). Patients with primary immune deficiencies (PIDs) affecting TLR signaling can elucidate the importance of these proteins in the human immune system. Defects in interleukin-1 receptor-associated kinase-4 and myeloid differentiation factor 88 (MyD88) lead to susceptibility to infections with bacteria, while mutations in nuclear factor-κB essential modulator (NEMO) and other downstream mediators generally induce broader susceptibility to bacteria, viruses, and fungi. In contrast, TLR3 signaling defects are associated with susceptibility to herpes simplex virus type 1 encephalitis. Other PIDs induce functional alterations of TLR signaling pathways, such as common variable immunodeficiency in which plasmacytoid dendritic cell defects enhance defective responses of B cells to shared TLR agonists. Altered TLR responses to TLR2 and 4 agonists are seen in chronic granulomatous disease (CGD) and X-linked agammaglobulinemia (XLA). Enhanced TLR responses, meanwhile, are seen for TLRs 5 and 9 in CGD, TLRs 4, 7/8, and 9 in XLA, TLRs 2 and 4 in hyper IgE syndrome (HIES), and for most TLRs in adenosine deaminase deficiency. In this review we provide the reader with an update on the role of TLRs and downstream signaling pathways in PID disorders.
Issue Date: 14-Jan-2017
Date of Acceptance: 13-Jan-2017
URI: http://hdl.handle.net/10044/1/44147
DOI: https://dx.doi.org/10.1016/j.ejphar.2017.01.014
ISSN: 0014-2999
Publisher: Elsevier
Start Page: 49
End Page: 56
Journal / Book Title: European Journal of Pharmacology
Volume: 808
Copyright Statement: © 2017 Elsevier B.V. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor/Funder: Wellcome Trust
Funder's Grant Number: 093080/Z/10/Z
Keywords: Chronic granulomatous disease
IgE syndrome
Primary immune deficiencies
TLRs
Pharmacology & Pharmacy
1115 Pharmacology And Pharmaceutical Sciences
Publication Status: Published
Conference Place: Netherlands
Appears in Collections:National Heart and Lung Institute
Airway Disease
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons